Marcello Damiani
Director/Board Member presso BENEVOLENTAI
Profilo
Marcello Damiani is currently the Director at Cellarity Inc. and an Independent Non-Executive Director at BenevolentAI SA. He is also the Chief Digital & Operational Excellence Officer at ModernaTX, Inc. Previously, he worked as the Chief Information Officer & Senior Vice President at bioMérieux SA from 2010 to 2015.
He also held the position of Chief Digital & Operational Excellence Officer at Moderna, Inc. Mr. Damiani has a graduate degree from Université Fédérale Toulouse Midi-Pyrénées and an MBA from Trium Global Emba.
Posizioni attive di Marcello Damiani
| Società | Posizione | Inizio |
|---|---|---|
| BENEVOLENTAI | Director/Board Member | 04/05/2023 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 01/01/2019 |
Precedenti posizioni note di Marcello Damiani
| Società | Posizione | Fine |
|---|---|---|
| BIOMÉRIEUX | Chief Tech/Sci/R&D Officer | 01/01/2015 |
| MODERNA, INC. | Corporate Officer/Principal | - |
Formazione di Marcello Damiani
| Université Fédérale Toulouse Midi-Pyrénées | Graduate Degree |
| Trium Global Emba | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BIOMÉRIEUX | Health Technology |
| MODERNA, INC. | Health Technology |
| BENEVOLENTAI | Health Technology |
| Aziende private | 2 |
|---|---|
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Marcello Damiani
